The research compound in Vyleesi^®

Vyleesi^® is a hypoactive sexual desire disorder medicine from Cosette Pharmaceuticals. Its active compound is PT-141 — which is what this catalogue supplies, as a research material.

This is not Vyleesi^®, and NOVALYTE LABS has no affiliation with Cosette Pharmaceuticals. We supply the compound PT-141 for laboratory research only — not for human consumption, diagnostic, therapeutic or veterinary use. Vyleesi^® is a trademark of Cosette Pharmaceuticals, referenced here only to identify the compound.

Vyleesi is the brand for bremelanotide, the compound also known in research contexts as PT-141.

It is a melanocortin receptor agonist acting on MC3R and MC4R in the central nervous system — a mechanism distinct from the vascular one used by the older oral agents in that area.

PT-141 is listed here as a research material with batch documentation, not as the branded medicine.

PT-141 in this catalogue